Patient.info PatientProfessionalArticle https://patient.info/doctor/rss Latest updates from Patient.info PatientProfessionalArticle Copyright 2026 Patient.info Field Safety Notices: 27 to 31 July 2026 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/field-safety-notices-27-to-31-july-2026 2eMqd0p2cY0znUqw2bv5mc 2026-08-04T14:34:58.000Z Dräger Atlan Anaesthesia workstations: risk of ventilator failure (DSI/2026/005) Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/drager-atlan-anaesthesia-workstations-risk-of-ventilator-failure-dsi-slash-2026-slash-005 3n1gtRNkj9knxY3gsCceuo 2026-08-04T13:00:13.000Z 400 - NHS Primary Care Bulletin - 30 July 2026 Thomas Andrew Porteus, MBCS https://patient.info/doctor/nhs-bulletin/400 115dNbMMBJdUPJ97SMUZ0I 2026-07-30T15:33:21.000Z MHRA Safety Roundup: July 2026 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/mhra-safety-roundup-july-2026 5R73yB4nlBnix8DeFXcyXL 2026-07-30T13:03:00.000Z Hereditary haemochromatosis https://patient.info/doctor/haematology/hereditary-haemochromatosis doc_2256 2026-07-29T00:00:00.000Z Field Safety Notices: 20 to 24 July 2026 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/field-safety-notices-20-to-24-july-2026 2Ih6o3sOQBprCBt5H3UPLb 2026-07-28T10:57:23.000Z 399 - NHS Primary Care Bulletin - 23 July 2026 Thomas Andrew Porteus, MBCS https://patient.info/doctor/nhs-bulletin/399 1d4FJu5V6aNoWzVOCzwfmD 2026-07-23T15:18:34.000Z Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/class-4-medicines-defect-notification-neuraxpharm-uk-ltd-tuzulby-prolonged-release-chewable-tablets-el-26-a-slash-36 6BgLmEcC3BONCLdji31xGX 2026-07-23T10:03:27.000Z Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/domperidone-new-contraindication-in-patients-with-phaeochromocytoma-due-to-the-risk-of-severe-hypertension BneupAKVIV9SraSe55jKN 2026-07-21T13:00:37.000Z Field Safety Notices: 13 to 17 July 2026 Medicines and Healthcare products Regulatory Agency (MHRA) https://patient.info/doctor/drug-device-alert/field-safety-notices-13-to-17-july-2026 6n2yuVswwb4rkVSvcNEqq0 2026-07-21T08:16:08.000Z